Source: International Congress 2017 – COPD biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Pascoe (King of Prussia, United States of America). Assessing E-RS to measure symptoms in COPD patients with a reversible component. 3599

Member's Comments

No comment yet.

Related content which might interest you: Evaluating acute bronchodilator response with subjective and objective criteria in stable COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 64s Year: 2005 Characterising symptom ‘trajectotypes’ in patients with COPD Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Assessing COPD profiles and outcomes by dyspnoea severity Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Detection of acute health status deterioration among COPD patients by monitoring COPD assessment test score Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 520s Year: 2004 Do COPD severity parameters predict mood disorders? Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 The relationship between symptom scores and medication adherence in stable COPD patients Source: International Congress 2017 – COPD management Year: 2017 Do COPD patients take timely measures in periods of symptom deterioration? Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Asthma patients adjust their maintenance treatment late in response to worsening asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 7s Year: 2005 Prolonged effect of exacerbations on fatigue and depression in moderate clinically stable COPD Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Evaluation of change in fatigue after pulmonary rehabilitation programme in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 96s Year: 2007 Impact of stable state symptoms on the future burden of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018